Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients. - Wikidata - awgldk - TriplyDB

Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.

Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.

http://www.wikidata.org/entity/Q43611407

about

Risk factors associated with adverse reactions to antituberculosis drugs PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2 Isoniazid metabolism and hepatotoxicity Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1 Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patients Meta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene Polymorphisms Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS.Evaluation of cytochrome P4502E1 polymorphisms in healthy adult Western Indians and patients with antituberculous drug-induced hepatotoxicity.CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid.Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.Latest advances in predicting DILI in human subjects: focus on biomarkers.GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis.Drug-induced liver injury: the role of drug metabolism and transport.Update meta-analysis of the CYP2E1 RsaI/PstI and DraI polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies.Drug metabolism and liver disease: a drug-gene-environment interaction.NAT2 gene diversity and its evolutionary trajectory in the Americas.Antioxidant status and GST gene polymorphisms in antitubercular treatment-induced hepatotoxicity patients.Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes.Intrathecal Isoniazid for Refractory Tuberculous Meningitis with Cerebral Infarction PharmGKB summary: isoniazid pathway, pharmacokinetics.PharmGKB summary: very important pharmacogene information for GSTT1.Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis.The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis.Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population.The effect of ageing on isoniazid pharmacokinetics and hepatotoxicity in Fischer 344 rats.

P2860

Q26863380-2528E056-9106-4024-949B-5523986A5E0C Q27011622-C70762BA-0BA0-47E7-94BB-8D8C467E53E2 Q28076859-B1375C78-52CF-4DEB-BC56-85148EFC938C Q28484468-9B310F27-033F-4467-8E4B-E5896C343E33 Q28486869-D99CD28E-7BEF-4BA4-91C0-613874D59006 Q28539060-601134F3-9D72-4DD6-A990-AD050F7425A3 Q28542785-56549957-D427-4B32-8F6B-6FA5D8530733 Q28547892-67AFA7C3-BF5A-4518-BFC0-FDCAFA3BB8EE Q34986858-18AA2D3B-622E-46AD-840E-43EC2CBE3329 Q36058879-BCD260A3-6A84-43F2-9E4F-ACF308ED32DF Q36651440-B3F5E3F0-8927-4EE8-A96B-59724EECB3D0 Q36867088-9FF720D0-8DAE-4B99-84CF-DA7F4A8740FA Q37590883-D99931D2-A831-4BCB-B27D-88EFA899B90C Q38045377-93B11EA9-3E0F-4C04-8928-30712189DE31 Q38078780-F3B3B4E2-24C7-4C91-A910-0882C6830F68 Q38084215-16986CCA-7172-4B95-A3E0-90F01217557F Q38381479-5FCCB27D-D137-4A1E-BFBB-5BBE1C389F10 Q39037269-40216E26-02C5-42B8-9162-A98D8E8B7567 Q40390254-4E0ECAEC-2B65-4A34-B057-94953AC33394 Q40706938-9EAFE4A6-32C2-429F-ACFC-B9BA2272AED4 Q41068782-252E9E1A-0685-4A73-962E-56C2DD36B854 Q42026631-33942AC6-3286-4535-9DBE-0CA5A88CE47F Q42090708-F0DB6E76-F4FE-4B2B-8554-A780DC3D1559 Q42235207-AAE55462-CB79-4462-A4E9-8B27B656B8A5 Q42708451-9A09EDBC-A0B4-4960-A842-676097DAEBC1 Q43474583-55285D08-5BFA-4F2F-A876-670C7A7248B2 Q43567165-A552BF11-2D29-467A-BA5F-EF7316F0AE13 Q43754598-E73623BD-2907-4381-A860-9A54E2A5C29F Q45766101-050A2BAE-DF37-4A7D-94FA-8BDB78E290DF Q51325880-DDC4EC48-C56B-4386-9C1A-42E819A79551 Q51569750-070E659B-0F1B-4D1E-A52A-5F24D0AEF10C Q53734594-368447E1-C334-42EB-8390-FE0188F2AE03 Q55022756-8F3F2F78-F531-46D6-A2B9-E855B7A8D5C9

P2860

Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.

http://www.wikidata.org/entity/Q43611407

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.

@en

Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.

@nl

type

label

Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.

@en

Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.

@nl

prefLabel

Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.

@en

Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.

@nl

P1433

Q43611407-EDE006CD-99CB-4FE5-B71F-9794E0940885

P1476

Q43611407-29EFBB8E-55CC-4207-BB9B-12F7E5E1A07A

P2093

Q43611407-1ABEE805-64D5-4488-AF28-3FF51DE21DB3

Q43611407-2688DDF8-A59B-48D5-B996-F384648F8472

Q43611407-2CBB79A2-70A5-4ADB-9B75-BF6B53B53F2B

Q43611407-357F7771-BB78-4785-B216-18E3A9ABD632

Q43611407-5F6F6090-16E7-4718-957B-1268F536925C

Q43611407-695B2D9D-6499-4786-9A1D-F5E1FFF4BC36

Q43611407-6C666E3F-E772-4BFC-9979-67B7EC0DADB1

Q43611407-984FD615-401D-48E7-B516-EF21CC61F840

Q43611407-99A0FA44-8E1F-470D-88F5-0072FD3298EE

Q43611407-EB59FAC1-8262-40DD-B812-9CC0FC79C817

P2860

Q43611407-07DFDFF9-3E04-49CB-82F4-03755D7A12F8

Q43611407-11803D99-3780-4768-9BA8-64C0288D7D7C

Q43611407-19B13AAE-8040-4C36-B15B-7D0D2A632CD3

Q43611407-1C953F4E-07B0-4AD8-A779-CD4636F3315D

Q43611407-26310435-8563-4ECB-B460-F622164469A4

Q43611407-37984529-EDD3-4F5E-820E-C0E770190B7F

Q43611407-3805F54C-D7DF-4583-9043-3817482056B1

Q43611407-40A8DBFB-5CA6-46F6-A295-7DF9919F434B

Q43611407-4A420930-0513-42BA-8B49-C464AA2860A7

Q43611407-4A628D4A-C0FF-485C-AD03-F2A245C2F755

P304

Q43611407-5515D70F-8E3F-4045-AA28-F9183440D14A

P31

Q43611407-E03F963E-842E-415D-9CD7-4904BBB46C83

P356

Q43611407-B7EA376A-2B65-4139-81BB-1BE44BE5A70C

P433

Q43611407-326D22EE-376E-4829-8AC7-7C901C53B04F

P478

Q43611407-56C0CC2E-C92E-43A7-8DDE-FAD5BA37987C

P577

Q43611407-7CAA1739-F126-49A8-A7A3-34E449FDA427

P5875

Q43611407-1A19C923-8A0A-43A6-8C3E-7209BB321A18

P698

Q43611407-37B81356-3EAB-440B-9073-CE44CC36CBAF

P356

S0074-02762011000600011

P1433

Memórias do Instituto Oswaldo Cruz

P1476

Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.

@en

P2093

Adalberto Rezende Santos

http://www.w3.org/2001/XMLSchema#string

Adriana da Silva Rezende Moreira

http://www.w3.org/2001/XMLSchema#string

Afrânio Lineu Kritski

http://www.w3.org/2001/XMLSchema#string

Antonio Basilio de Miranda

http://www.w3.org/2001/XMLSchema#string

Fernanda Carvalho Queiroz Mello

http://www.w3.org/2001/XMLSchema#string

Ligia Mayumi Kitada Muniz

http://www.w3.org/2001/XMLSchema#string

Pedro Hernan Cabello

http://www.w3.org/2001/XMLSchema#string

Philip Noel Suffys

http://www.w3.org/2001/XMLSchema#string

Raquel Lima de Figueiredo Teixeira

http://www.w3.org/2001/XMLSchema#string

Renata Gomes Morato

http://www.w3.org/2001/XMLSchema#string

P2860

A New Statistical Method for Haplotype Reconstruction from Population Data

A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Glutathione transferases

Sequence analysis of NAT2 gene in Brazilians: identification of undescribed single nucleotide polymorphisms and molecular modeling of the N-acetyltransferase 2 protein structure.

Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?

Drug-induced hepatotoxicity.

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.

An official ATS statement: hepatotoxicity of antituberculosis therapy.

The role of biotransformation in chemical-induced liver injury.

Toxic hepatitis with isoniazid and rifampin. A meta-analysis.

P304

716-724

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0074-02762011000600011

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51731064

http://www.w3.org/2001/XMLSchema#string

P698

22012226

http://www.w3.org/2001/XMLSchema#string